Advertisement

Pharmacokinetics in the Geriatric Population

  • Alfonso Dominguez-Gil Hurlé
  • M.J. García Sánchez
  • M.M. Fernández De Gatta
  • Ampara Sánchez Navarro

Keywords

Chronic Kidney Disease Geriatric Patient Hepatic Clearance Geriatric Population National Kidney Foundation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Burton, P.S., Goodwin, J.T., Vidmar, T.J., et al. Predicting drug absorption: How nature made it a difficult problem. J. Pharmacol. Exp. Ther. 2002; 303:889–895.PubMedCrossRefGoogle Scholar
  2. 2.
    Hurwitz, A., Brady, D.A., Schaal, S.E., et al. Gastric acidity in older adults. JAMA 1997; 278:659–662.PubMedCrossRefGoogle Scholar
  3. 3.
    Orr, W.C., Chen, C.L. Aging and neural control of the GI tract: IV. Clinical and physiological aspects of gastrointestinal motility and aging. Am. J. Physiol. 2002; 283:G1226–G1231.Google Scholar
  4. 4.
    Gainsboroug, N., Maskrey, V.L., Nelson, M.L., et al. The association of age with gastric emptying. Age and Ageing 1993; 22:37–40.CrossRefGoogle Scholar
  5. 5.
    Firth, M., Prather, C.M. Gastrointestinal motility problems in the elderly patient. Gastroenterology 2002; 122:1688–1700.PubMedCrossRefGoogle Scholar
  6. 6.
    Saltzman, J.R., Kowdley, K.V., Perrone, G., et al. Changes in small intestine permeability with aging. J. Am. Geriatr. Soc. 1995; 43:160–164.PubMedGoogle Scholar
  7. 7.
    Turnheim, K. Drug dosage in the elderly. Is it rational? Drugs & Aging 1998; 13(5): 357–379.CrossRefGoogle Scholar
  8. 8.
    Sacchi, V.F., Magagnin, S. Age-related modifications of leucine uptake in brush-border membrane vesicles from rat jejunum. Mech. Ageing Dev. 1992; 63:257–273.PubMedCrossRefGoogle Scholar
  9. 9.
    McLean, A.J., Le Couteur, D.G. Aging biology and geriatric clinical pharmacology. Pharmacol. Rev. 2004; 56:163–184.PubMedCrossRefGoogle Scholar
  10. 10.
    Wilkinson, G.R. The effects of diet, aging and disease-states on presystemic elimination and oral drug bioavailability in humans. Adv. Drug. Deliv. Rev. 1997; 27:129–159.PubMedCrossRefGoogle Scholar
  11. 11.
    Roskos, K.V., Maibach, H.I., Guy, R.A. The effect of aging on percutaneous absorption in man. J. Pharmacokinet. Biopharm. 1989; 17:617–630.PubMedCrossRefGoogle Scholar
  12. 12.
    Beaufrere, B., Morio, B. Fat and protein redistribution with aging: Metabolic considerations. Eur. J. Clin. Nutr. 2000; 54:S48–S53.PubMedGoogle Scholar
  13. 13.
    Bressler, R., Bahl, J.J. Principles of drug therapy for the elderly patients. Mayo Clin. Proc. 2003; 78:1564–1577.PubMedCrossRefGoogle Scholar
  14. 14.
    Campion, E.W., deLabry, L.O., Glynn, R.J. The effect of age on serum albumin in healthy males: Report from the Normative Aging Study. J. Gerontol. 1988; 43:M18–M20.PubMedGoogle Scholar
  15. 15.
    Wallace, S.M., Verbeek, R.K. Plasma protein binding in the elderly. Clin. Pharmacokinet. 1987; 12:41–72.PubMedGoogle Scholar
  16. 16.
    Grandison, M.K., Boudinot, F.D. Age-related changes in protein binding of drugs: Implications for therapy. Clin. Pharmacokinet. 2000; 38:271–290.PubMedCrossRefGoogle Scholar
  17. 17.
    Benet, L.Z., Hoener, B.A. Changes in plasma protein binding have little clinical relevance. Clin. Pharmacol. Ther. 2002; 71:115–121.PubMedCrossRefGoogle Scholar
  18. 18.
    Mangoni, A.A., Jackson, S.H. Age-related changes in pharmacokinetics and pharmacodynamics: Basic principles and practical applications. Br. J. Clin. Pharmacol. 2004; 57(1):6–14.PubMedCrossRefGoogle Scholar
  19. 19.
    Schmucker, D.L. Liver function and phase I drug metabolism in the elderly. A paradox. Drugs & Aging 2001; 18:837–851.CrossRefGoogle Scholar
  20. 20.
    Bebia, Z., Buch, S.C., Wilson, J.W., et al. Bioequivalence revisited: Influence of age and sex on CYP enzimes. Clin. Pharmacol. Ther. 2004; 76:618–627.PubMedCrossRefGoogle Scholar
  21. 21.
    Ishizawa, Y., Yasui-Furukori, N., Takahata, T., et al. The effect of aging on the relationship between the cytochrome P450 2C19 genotype and omeprazole pharmacokinetics. Clin. Pharmacokinet. 2005; 44:1179–1189.PubMedCrossRefGoogle Scholar
  22. 22.
    Ginsberg, G., Hattis, D., Russ, A., et al. Pharmacokinetic and pharmacodynamic factors that can affect sensitivity to neurotoxic sequelae in elderly individuals. Environ. Health Perspect. 2005; 113:1243–1249.PubMedCrossRefGoogle Scholar
  23. 23.
    Zeeh, J., Platt, D. The aging liver. Structural and functional changes and their consequences for drug treatment in old age. Gerontology 2002; 48:121–127.PubMedCrossRefGoogle Scholar
  24. 24.
    Kinirons, M.T., O’Mahony, M.S. Drug metabolism and ageing. Br. J. Clin. Pharmacol. 2004; 57:540–544.PubMedCrossRefGoogle Scholar
  25. 25.
    Sotaniemi, E.A., Arranto, A.J., Pelkonen, O., et al. Age and cytochrome P450-linked drug metabolism in humans: An analysis of 226 subjects with equal histopathological conditions. Clin. Pharmacol. Ther. 1997; 61:331–339.PubMedCrossRefGoogle Scholar
  26. 26.
    Levey, A.S., Coresh, J., Balk, E., et al. National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease. Evaluation, classification and stratification. Ann. Intern. Med. 2003; 139:137–147.PubMedGoogle Scholar
  27. 27.
    Bailie, G.R., Uhlig, K., Levey, A.S. Clinical practice guidelines in Nephrology: Evaluation, classification and stratification of chronic kidney disease. Pharmacotherapy 2005; 25:491–502.PubMedCrossRefGoogle Scholar
  28. 28.
    Cockcroft, D.W., Gault, M.H. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31–41.PubMedGoogle Scholar
  29. 29.
    Burkhardt, H., Bojarski, G., Gretz, N., et al. Creatinine clearance, Cockcroft–Gault formula and cystatin C: Estimators of true glomerular filtration rate in the elderly? Gerontology 2002; 48:140–146.PubMedCrossRefGoogle Scholar
  30. 30.
    Fliser, D., Ritz, E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am. J. Kidney Dis. 2001; 37:79–83.PubMedGoogle Scholar
  31. 31.
    Tett, S.E., Kirkpatrick, C.M.J., Gross, A.S., et al. Principles and clinical application of assessing alterations in renal elimination pathways. Clin. Pharmacokinet. 2003; 6:45–65.Google Scholar
  32. 32.
    Matzke, G.R., Comstock, T.J. Influence of renal function and dialysis on drug disposition. In Applied Pharmacokinetics and Pharmacodynamics, M.E. Burton, L.M. Shaw, J.J. Schentag, and W.E. Evans, eds. London: Lippincott Williams and Wilkins. 2006; pp. 187–212.Google Scholar
  33. 33.
    Gabardi, S., Abramson, S. Drug dosing in chronic kidney disease. Med. Clin. N. Am. 2005; 89:649–687.PubMedCrossRefGoogle Scholar
  34. 34.
    Conway, B.R., Fogarty, D.G., Nelson, W.E., et al. Opiate toxicity in patients with renal failure. Br. Med. J. 2006; 332:345–346.CrossRefGoogle Scholar
  35. 35.
    Angst, M.S., Buhrer, M., Lotsch, J. Insidious intoxication after morphine treatment in renal failure: Delayed onset of morphine-6-glucuronide action. Anesthesiology 2000; 92:1473–1476.PubMedCrossRefGoogle Scholar
  36. 36.
    Gelman, R.S., Taylor, S.G.T. Cyclophosphamide, metotrexate, and 5-fluorouracil chemotherapy in women more than 65 years old with advanced breast cancer: The elimination of age trend in toxicity by using dosed based on creatinine clearance. J. Clin. Onc. 1984; 2:1404–1413.Google Scholar
  37. 37.
    Pillans, P.I., Landsberg, P.G., Fleming, A.M., et al. Evaluation of dosage adjustment in patients with renal impairment. Int. Med. J. 2003; 33:10–13.CrossRefGoogle Scholar
  38. 38.
    McCormack, J.P., Cooper, J., Carleton, B. Simple approach to dosage adjustment in patients with renal impairment. Am. J. Health Syst. Pharm. 1997; 54:2505–2509.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Alfonso Dominguez-Gil Hurlé
  • M.J. García Sánchez
  • M.M. Fernández De Gatta
  • Ampara Sánchez Navarro

There are no affiliations available

Personalised recommendations